Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Iyengar Yoga's effects on postmenopausal women's health

Official title: A Single-center, Randomized, Controlled, Open-labelled, Two-armed, Interventional Clinical Trial Investigating the Effect of a 12 Week Iyengar Yoga Intervention on the Bio-functional Age of Postmenopausal Women.

Run by Insel Gruppe AG, University Hospital Bern · NCT04705623 · Data updated 2026-11-12

This study is testing if a 12-week Iyengar Yoga program can help improve the health and well-being of postmenopausal women.

More Postmenopausal trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment72 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations1 site (Bern)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedMarch 31, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 5, 2025
Trial IDNCT04705623 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are postmenopausal women over 18 years old experiencing at least four hot flushes per day and who have not practiced yoga regularly for the past two years.

Probably not a fit

Patients with serious acute diseases, autoimmune disorders, or mental health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether Iyengar Yoga can have a rejuvenating effect on postmenopausal women by assessing their biofunctional status before and after a 12-week yoga program. Participants will be randomly assigned to either an intervention group, which will attend yoga sessions led by a professional instructor and practice at home, or a control group. The study aims to evaluate changes in biofunctional age through various assessments, including blood samples and self-reported data on menopausal symptoms. The research is conducted at the University Hospital Bern, where participants will be recruited and monitored throughout the program.

Why it matters

Potential benefit: If successful, this study could provide a non-pharmacological approach to alleviate menopausal symptoms and improve overall health in postmenopausal women.

How similar studies have gone: While the specific approach of Iyengar Yoga for this demographic is novel, similar studies have shown positive outcomes for yoga in managing menopausal symptoms.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent
* Women after Menopause (defined as 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels \>40mlU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy)
* Age over 18 years
* At least 4 hot flushes per day (examined through the Menopause rating scale MRS-II)
* No regular yoga practice for two years
* German as native language
* Willing to participate in 12 yoga classes as well as two 45 self practice sessions per week
* Willing to assess biofunctional Status and give blood samples

Exclusion Criteria:

* Acute and/or serious disease in the past two years (e.g. Cancer, major surgery)
* Autoimmune or chronic inflammatory disease (e.g. rheumatism, thyroid dysfunction)
* Mental illness (e.g. Depression or anxiety disorder (HADS \>8))
* Acute or chronic back pain or herniated vertebral disc
* Compulsion to participate in the trial
* Attendance of less than 10 yoga lessons out of 12.
* Hormone replacement therapy (HRT)
* Smoking \> 20 Cigarettes per day or over 20 packyears
* Consumption of \>30g alcohol per day (\>1 liter of beer or \>0.3 dl of wine)
* Previous periodic participation in yoga classes within the last two years
* Inability or contraindications to undergo the investigated intervention
* Participants incapable of judgement or participants under tutelage Diabetes mellitus

Where it's running

  • Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern
    Bern, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Petra Stute, Prof. Dr. med — Universitätsklinik für Frauenheilkunde Bern
  • Study coordinator: Petra o Stute, Prof. Dr. med
  • Email: petra.stute@insel.ch
  • Phone: +41 31 63 2 13 33

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.